ADVANCED LEIOMYOSARCOMA
Clinical trials for ADVANCED LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for ADVANCED LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for sarcoma: drug combo aims to slow tumor growth
Disease control Recruiting nowThis study tests a new two-drug treatment for people with advanced soft tissue sarcoma that has spread. The drugs, abemaciclib and gemcitabine, work together to stop cancer cells from multiplying. The goal is to see if this combination is safer and works better than the current s…
Matched conditions: ADVANCED LEIOMYOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 05:36 UTC
-
New drug combo aims to slow rare sarcomas
Disease control Recruiting nowThis early-phase trial tests whether combining two drugs—zanzalintinib and eribulin—is safe and can help people with advanced liposarcoma or leiomyosarcoma live longer without their cancer growing. About 18 adults whose cancer has worsened after at least one prior treatment will …
Matched conditions: ADVANCED LEIOMYOSARCOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 17, 2026 05:33 UTC